- Correction
- Open Access
- Published:
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
Orphanet Journal of Rare Diseases volume 16, Article number: 329 (2021)
The Original Article was published on 15 February 2021
Correction to: Orphanet J Rare Dis (2021) 16:86 https://doi.org/10.1186/s13023-020-01658-4
Following the publication of the original article [1] the authors informed us of an error in the second paragraph under ‘Study population’ of the ‘Results’ section.
The paragraph should read:
“Half of the patients in the study (n = 64, 50.8%) were participants in the double-blind COMPACT study, thus were using C1-INH(SC) prophylaxis prior to continuing into the open-label study (Table 1). An additional 15 patients (11.9%) were using other forms of HAE prophylaxis (intravenous C1-INH [C1-INH[IV)] or oral danazol) within the 3-month period prior to the open-label study”.
The original article has already been updated as above.
Reference
Lumry, et al. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis. 2021;16:86. https://doi.org/10.1186/s13023-020-01658-4.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lumry, W.R., Zuraw, B., Cicardi, M. et al. Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis 16, 329 (2021). https://doi.org/10.1186/s13023-021-01975-2
Published:
DOI: https://doi.org/10.1186/s13023-021-01975-2